University of California, Davis Comprehensive Cancer Center — Sacramento, California

Public research footprint of University of California, Davis Comprehensive Cancer Center, compiled from the ClinicalTrials.gov public registry.

596

Registered studies

322

Active

114

Recruiting now

204

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Lung Non-Small Cell Carcinoma · Clear Cell Renal Cell Carcinoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT05687110 — Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With… (Recruiting)
NCT06317649 — Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of California, Davis Comprehensive Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.